 Michele Yang
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Duchenne | 7 | 2025 | 93 | 1.770 |
Why?
| | Dystrophin | 2 | 2025 | 41 | 1.090 |
Why?
| | Developmental Disabilities | 1 | 2025 | 281 | 0.730 |
Why?
| | Telomere | 1 | 2025 | 287 | 0.720 |
Why?
| | Neurodevelopmental Disorders | 1 | 2025 | 226 | 0.710 |
Why?
| | Neuromuscular Diseases | 2 | 2026 | 145 | 0.600 |
Why?
| | Body Height | 3 | 2016 | 201 | 0.560 |
Why?
| | Body Weight | 3 | 2016 | 969 | 0.450 |
Why?
| | Myelitis | 3 | 2026 | 107 | 0.440 |
Why?
| | Neural Conduction | 4 | 2026 | 92 | 0.380 |
Why?
| | Child Development | 1 | 2016 | 483 | 0.330 |
Why?
| | Spinal Muscular Atrophies of Childhood | 3 | 2014 | 18 | 0.300 |
Why?
| | Myopathies, Structural, Congenital | 2 | 2019 | 4 | 0.290 |
Why?
| | Body Mass Index | 3 | 2016 | 2437 | 0.280 |
Why?
| | Motor Neurons | 3 | 2016 | 236 | 0.280 |
Why?
| | Electrodiagnosis | 1 | 2026 | 17 | 0.240 |
Why?
| | Action Potentials | 4 | 2026 | 502 | 0.220 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2026 | 78 | 0.220 |
Why?
| | Survival of Motor Neuron 1 Protein | 2 | 2014 | 11 | 0.210 |
Why?
| | Pregnadienediols | 1 | 2024 | 3 | 0.210 |
Why?
| | Child, Preschool | 15 | 2026 | 11835 | 0.210 |
Why?
| | Infant | 9 | 2025 | 10060 | 0.200 |
Why?
| | Respiration, Artificial | 2 | 2019 | 713 | 0.200 |
Why?
| | Genetic Therapy | 1 | 2025 | 315 | 0.190 |
Why?
| | Muscle, Skeletal | 3 | 2017 | 1789 | 0.160 |
Why?
| | Polyneuropathies | 2 | 2014 | 57 | 0.160 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.160 |
Why?
| | Prednisone | 2 | 2024 | 221 | 0.160 |
Why?
| | Adaptation, Physiological | 2 | 2014 | 560 | 0.160 |
Why?
| | Mutation, Missense | 2 | 2019 | 335 | 0.150 |
Why?
| | Neurology | 1 | 2021 | 116 | 0.150 |
Why?
| | Patient Admission | 1 | 2021 | 220 | 0.150 |
Why?
| | Alcohol Oxidoreductases | 1 | 2019 | 61 | 0.140 |
Why?
| | Nervous System Diseases | 1 | 2021 | 286 | 0.140 |
Why?
| | Neuroimaging | 1 | 2020 | 292 | 0.130 |
Why?
| | Male | 19 | 2026 | 72664 | 0.130 |
Why?
| | Patient Safety | 1 | 2021 | 355 | 0.130 |
Why?
| | Premature Birth | 2 | 2019 | 387 | 0.130 |
Why?
| | Cranial Nerve Diseases | 1 | 2017 | 44 | 0.130 |
Why?
| | Muscular Diseases | 1 | 2017 | 107 | 0.120 |
Why?
| | Movement Disorders | 1 | 2017 | 69 | 0.120 |
Why?
| | Child | 15 | 2026 | 22670 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 393 | 0.120 |
Why?
| | Pregnenediones | 1 | 2016 | 15 | 0.120 |
Why?
| | Muscle Weakness | 2 | 2014 | 92 | 0.120 |
Why?
| | Paralysis | 1 | 2016 | 69 | 0.120 |
Why?
| | Glucocorticoids | 2 | 2020 | 531 | 0.110 |
Why?
| | Muscular Dystrophy, Emery-Dreifuss | 1 | 2015 | 3 | 0.110 |
Why?
| | Electromyography | 4 | 2026 | 419 | 0.110 |
Why?
| | Respiration Disorders | 1 | 2016 | 78 | 0.110 |
Why?
| | Cytoplasmic Dyneins | 1 | 2015 | 8 | 0.110 |
Why?
| | Humans | 24 | 2026 | 145140 | 0.110 |
Why?
| | Cohort Studies | 5 | 2020 | 5988 | 0.110 |
Why?
| | Enterovirus D, Human | 1 | 2016 | 87 | 0.110 |
Why?
| | Muscular Atrophy, Spinal | 1 | 2015 | 24 | 0.110 |
Why?
| | Surgical Procedures, Operative | 1 | 2017 | 271 | 0.110 |
Why?
| | Gastrostomy | 1 | 2016 | 130 | 0.100 |
Why?
| | Enterovirus Infections | 1 | 2016 | 173 | 0.100 |
Why?
| | Growth | 1 | 2013 | 49 | 0.100 |
Why?
| | Enteral Nutrition | 1 | 2016 | 217 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2020 | 6435 | 0.100 |
Why?
| | Actins | 1 | 2015 | 424 | 0.090 |
Why?
| | Muscular Dystrophies | 1 | 2012 | 28 | 0.090 |
Why?
| | Respiratory Mechanics | 1 | 2012 | 74 | 0.090 |
Why?
| | Aspartate Aminotransferases | 1 | 2012 | 85 | 0.090 |
Why?
| | Weight Gain | 1 | 2016 | 561 | 0.090 |
Why?
| | Follow-Up Studies | 3 | 2017 | 5411 | 0.090 |
Why?
| | Alanine Transaminase | 1 | 2012 | 151 | 0.090 |
Why?
| | Telemedicine | 1 | 2021 | 956 | 0.090 |
Why?
| | DNA-Binding Proteins | 1 | 2019 | 1479 | 0.090 |
Why?
| | Motor Skills | 1 | 2012 | 104 | 0.090 |
Why?
| | Retrospective Studies | 6 | 2026 | 17247 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 2 | 2020 | 3892 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 2767 | 0.080 |
Why?
| | Muscle Strength | 1 | 2012 | 332 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2021 | 2377 | 0.070 |
Why?
| | Female | 13 | 2026 | 78636 | 0.070 |
Why?
| | Arthritis, Psoriatic | 1 | 2007 | 15 | 0.070 |
Why?
| | Critical Illness | 1 | 2014 | 899 | 0.060 |
Why?
| | Adolescent | 8 | 2020 | 22479 | 0.060 |
Why?
| | Young Adult | 6 | 2020 | 14176 | 0.060 |
Why?
| | Disease Progression | 3 | 2020 | 2857 | 0.050 |
Why?
| | Phenotype | 3 | 2019 | 3138 | 0.050 |
Why?
| | Mutation | 1 | 2015 | 4071 | 0.050 |
Why?
| | Utrophin | 1 | 2023 | 7 | 0.050 |
Why?
| | Sarcolemma | 1 | 2023 | 35 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 330 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3338 | 0.040 |
Why?
| | Adult | 7 | 2021 | 40665 | 0.040 |
Why?
| | Muscle Hypotonia | 1 | 2019 | 33 | 0.040 |
Why?
| | Tooth Abnormalities | 1 | 2019 | 16 | 0.040 |
Why?
| | Ataxia | 1 | 2019 | 69 | 0.040 |
Why?
| | Biomarkers | 2 | 2024 | 4282 | 0.030 |
Why?
| | Prognosis | 1 | 2026 | 4310 | 0.030 |
Why?
| | Intellectual Disability | 1 | 2019 | 178 | 0.030 |
Why?
| | Prospective Studies | 3 | 2014 | 8035 | 0.030 |
Why?
| | Atrophy | 1 | 2017 | 198 | 0.030 |
Why?
| | Echocardiography | 1 | 2020 | 647 | 0.030 |
Why?
| | Stroke Volume | 1 | 2020 | 653 | 0.030 |
Why?
| | Alleles | 1 | 2019 | 888 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2949 | 0.030 |
Why?
| | Myopathies, Nemaline | 1 | 2015 | 2 | 0.030 |
Why?
| | Glioblastoma | 1 | 2019 | 352 | 0.030 |
Why?
| | Brain | 2 | 2020 | 2934 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 378 | 0.030 |
Why?
| | Chromatin | 1 | 2019 | 553 | 0.030 |
Why?
| | Genetic Linkage | 1 | 2015 | 271 | 0.030 |
Why?
| | Peroneal Nerve | 1 | 2014 | 18 | 0.030 |
Why?
| | Sural Nerve | 1 | 2014 | 21 | 0.030 |
Why?
| | Exome | 1 | 2015 | 227 | 0.030 |
Why?
| | Pedigree | 1 | 2015 | 515 | 0.030 |
Why?
| | Middle Aged | 4 | 2021 | 36126 | 0.030 |
Why?
| | Neurologic Examination | 1 | 2014 | 132 | 0.030 |
Why?
| | Homozygote | 1 | 2014 | 199 | 0.030 |
Why?
| | Electrophysiology | 1 | 2014 | 218 | 0.020 |
Why?
| | Fibroblasts | 1 | 2019 | 1022 | 0.020 |
Why?
| | Age of Onset | 1 | 2015 | 554 | 0.020 |
Why?
| | Leg | 1 | 2015 | 242 | 0.020 |
Why?
| | Exons | 1 | 2014 | 363 | 0.020 |
Why?
| | Protein Binding | 1 | 2019 | 2235 | 0.020 |
Why?
| | Patient Reported Outcome Measures | 1 | 2017 | 497 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 2012 | 9 | 0.020 |
Why?
| | Gene Deletion | 1 | 2014 | 391 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1293 | 0.020 |
Why?
| | Proteomics | 1 | 2019 | 1185 | 0.020 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 54 | 0.020 |
Why?
| | Incidental Findings | 1 | 2012 | 81 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 844 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2016 | 2026 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2012 | 251 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2019 | 3539 | 0.020 |
Why?
| | Apoptosis | 1 | 2019 | 2434 | 0.020 |
Why?
| | Family | 1 | 2015 | 682 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2019 | 1328 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3616 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2014 | 924 | 0.020 |
Why?
| | Sepsis | 1 | 2014 | 662 | 0.020 |
Why?
| | Colorado | 1 | 2017 | 4538 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 10857 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2015 | 8318 | 0.010 |
Why?
| | Aged | 2 | 2014 | 26096 | 0.010 |
Why?
| | Animals | 1 | 2023 | 37952 | 0.010 |
Why?
| | Quality of Life | 1 | 2012 | 3194 | 0.010 |
Why?
| | United States | 1 | 2016 | 16065 | 0.010 |
Why?
|
|
Yang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|